• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Mayne Pharma Group Ltd

+ Add to Watchlist

MAYNF:US

0.6750 USD 0.0050 0.74%

As of 20:10:16 ET on 11/19/2014.

Snapshot for Mayne Pharma Group Ltd (MAYNF)

Open: 0.6750 Day's Range: 0.6750 - 0.6750 Volume: 600
Previous Close: 0.6800 52wk Range: 0.6200 - 0.9250 1-Yr Rtn: +8.87%

Stock Chart for MAYNF

No chart data available.
  • MAYNF:US 0.6750
  • 1D
  • 1M
  • 1Y
0.6800
Interactive MAYNF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MAYNF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 19.9420
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 0.0390
Est. PEG Ratio 1.0664
Market Cap (M USD) 396.87
Shares Outstanding (M) 587.95
30 Day Average Volume 2,330
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MAYNF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for MAYNF

Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.

Scott RichardsCEO/Managing Dir/Executive DirMark CansdaleCFO/Secretary
Ilana StancovskiChief Scientific Officer
More Company Profile & Key Executives for MAYNF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil